THE USE OF VITAMIN D PREPARATIONS TAKING INTO ACCOUNT VITAMIN D-DEFICIENT CONDITIONS

DOI: https://doi.org/10.29296/25877305-2024-04-06
Issue: 
4
Year: 
2024

E. Dontsеva(1, 2), Сandidate of Medical Sciences; T. Potupchik(1), Сandidate
of Medical Sciences; I. Gatskikh(1), Сandidate of Medical Sciences; T. Shalda(1)
1-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry
of Health of Russia
2-Federal Center of Neurosurgery, Ministry of Health of Russia, Novosibirsk

Currently, much attention is being paid to the status of vitamin D as a biomarker of the general state of human health, since low levels of vitamin D are associated with a wide range of diseases. Vitamin D metabolism is complex. Vitamin D and its containers can have genomic and non-genomic activity. The article presents the most common causes of vitamin D deficiency. Screening for vitamin D deficiency is shown in groups of patients with risk factors for its development. Individual features of vitamin D influence caused by genetic polymorphism of the VDR gene are described. For the prevention and treatment of vitamin D-deficient conditions, the use of the vitamin D preparation colecalciferol is recommended. Drugs with high activity calcitriol and alfacalcidol are necessary in certain groups of patients for strict indications, in particular in the complex therapy of osteoporosis.

Keywords: 
vitamin D
metabolism
risk factors
colecalciferol
calcitriol
alfacalcidol.



References: 
  1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A. et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911–30. DOI: 10.1210/jc.2011-0385
  2. Pannu P.K., Calton E.K., Soares M.J. Calcium and vitamin D in obesity and related chronic disease. Adv Food Nutr Res. 2016; 77: 57–100. DOI: 10.1016/bs.afnr.2015.11.001
  3. Holick M.F., Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87 (4): 1080–6. DOI: 10.1093/ajcn/87.4.1080S
  4. Шнайдер Н.А., Донцева Е.А., Насырова Р.Ф. Витамин D и болезнь Альцгеймера. Вестник Смоленской государственной медицинской академии. 2021; 20 (2): 65–76 [Schneider N.A., Dontsova E.A., Nasyrova R.F. Vitamin D and Alzheimer's disease. Bulletin of the Smolensk State Medical Academy. 2021; 20 (2): 65–76 (in Russ.)]. DOI: 10.37903/vsgma.2021.2.9
  5. Di Somma C., Scarano E., Barrea L. et al. Vitamin D and neurological diseases: an endocrine view. Int J Mol Sci. 2017; 18 (11): 2482. DOI: 10.3390/ijms18112482
  6. Uhlen M., Karlsson M.J., Zhong W. et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019; 366 (6472): eaax9198. DOI: 10.1126/science.aax9198
  7. Pertea M., Salzberg S.L. Between a chicken and a grape: estimating the number of human genes. Genome Biol. 2010; 11 (5): 206. DOI: 10.1186/gb-2010-11-5-206
  8. Ramagopalan S.V., Heger A., Berlanga A.J. et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010; 20 (10): 1352–60. DOI: 10.1101/gr.107920.110
  9. Balden R., Selvamani A., Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012; 153 (5): 2420–35. DOI: 10.1210/en.2011-1783
  10. Eyles D.W., Smith S., Kinobe R. et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005; 29 (1): 21–30. DOI: 10.1016/j.jchemneu.2004.08.006
  11. Garcion E., Wion-Barbot N., Montero-Menei C.N. et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metabol. 2002; 13 (3): 100–5. DOI: 10.1016/s1043-2760(01)00547-1
  12. Дефицит витамина D. Клинические рекомендации. Российская Ассоциация Эндокринологов. 2021 [Vitamin D deficiency. Clinical recommendations. Russian Association of Endocrinologists. 2021 (in Russ.)].
  13. Koutkia P., Chen T.C., Holick M.F. Vitamin D Intoxication Associated with an Over-the-Counter Supplement. N Engl J Med. 2001; 345 (1): 66–7. DOI: 10.1056/NEJM200107053450115
  14. Генетический паспорт – основа индивидуальной и предиктивной медицины. Под ред. В.С. Баранова. СПб., 2009 [The genetic passport is the basis of individual and predictive medicine. Ed. by V.S. Baranov. SPb, 2009 (in Russ.)].
  15. Holick M.F., Binkley N.C., Heike A. et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012; 97 (4): 1153–8. DOI: 10.1210/jc.2011-2601
  16. Климова О.Ю., Бердникова Н.Г., Казаков Р.Е. Клинико-фармакологические аспекты применения витамина D: от известных фактов к поиску новых мишеней. Consilium Medicum. 2016; 18 (2): 109–16 [Klimova O.Yu., Berdnikova N.G., Kazakov R.E. Clinical and pharmacological aspects of vitamin D use: from known facts to the search for new targets. Consilium Medicum. 2016; 18 (2): 109–16 (in Russ.)].
  17. Richard А., Sab R., Katharina C. Prevalence of Vitamin D eficiency and Its Associations with Skin Color in Pregnant Women inthe First Trimester in a Sample from Switzerland. Nutrients. 2017; 9: 260. DOI: 10.3390/nu9030260
  18. Yun C., Chen J., He Y. et al. Vitamin D deficiency prevalence and risk factors among pregnant Chinese women. Public Health Nutr. 2015; 20 (10): 1746–54. DOI: 10.1017/S1368980015002980
  19. Батанина И.А., Воробьева Е.Н., Воробьев Р.И. Витамин D: строение, функции, клиническое значение. Справочник заведующего КДЛ. 2021; 3: 52–63 [Batanina I.A., Vorobyeva E.N., Vorobyev R.I. Vitamin D: structure, functions, clinical significance. Handbook of the head of CDL. 2021; 3: 52–63 (in Russ.)].
  20. Захарова И.Н., Мальцев С.В., Боровик Т.Э. и др. Результаты многоцентрового исследования «РОДНИЧОК» по изучению недостаточности витамина D у детей раннего возраста в России. Педиатрия. Журнал им. Г.Н. Сперанского. 2015; 94 (1): 62–7 [Zakharova I.N., Maltsev S.V., Borovik T.E. et al. Results of a multicenter research «RODNICHOK» for the study of vitamin d insufficiency in infants in Russia. Pediatria n.a. G.N. Speransky. 2015; 94 (1): 62–7 (in Russ.)].
  21. Суплотова Л.А., Авдеева В.А., Пигарова Е.А. и др. Первое российское многоцентровое неинтервенционное регистровое исследование по изучению частоты дефицита и недостаточности витамина D в Российской Федерации у взрослых. Терапевтический архив. 2021; 93 (10): 1209–16 [Suplotova L.A., Avdeeva V.A., Pigarova E.A. et al. The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation. Terapevticheskii Arkhiv. 2021; 93 (10): 1209–16 (in Russ.)]. DOI: 10.26442/00403660.2021.10.201071
  22. Каронова Т.Л. Метаболические и молекулярно-генетические аспекты обмена витамина D и риск сердечно-сосудистых заболеваний у женщин. Дис. … д-ра мед. наук. СПБ, 2014 [Karonova T.L. Metabolic and molecular genetic aspects of vitamin D metabolism and the risk of cardiovascular diseases in women. Dis. ... d-ra med. nauk. Saint Petersburg, 2014 (in Russ.)].
  23. Beveridge L.A., Witham M.D. Vitamin D and the cardiovascular system. Osteoporos Int. 2013; 24 (8): 2167–80. DOI: 10.1007/s00198-013-2281-1
  24. Дедов И.И., Мельниченко Г.А. Российские клинические рекомендации. Эндокринология. М.: ГЭОТАР-Медиа, 2016 [Dedov I.I., Melnichenko G.A. Russian clinical guidelines. Endocrinology. M.: GEOTAR-Media, 2016 (in Russ.)].
  25. Дрыгина Л.Б., Дорофейчик-Дрыгина Н.А., Прохорова О.В. Статус витамина D при формировании остеодефицита у пожарных МЧС России. Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. 2013; 3: 5–9 [Drygina L.B., Dorofeychik-Drygina N.A., Prokhorova O.V. The status of vitamin D in the formation of osteodeficiency in firefighters of the EMERCOM of Russia. Biomedical and socio-psychological problems of safety in emergency situations. 2013; 3: 5–9 (in Russ.)].
  26. Мальцева Л.И., Васильева Э.Н., Денисова Т.Г. и др. Обеспеченность витамином D и коррекция его дефицита при беременности. Практическая медицина. 2017; 5 (106): 18–21 [Maltseva L.I., Vasilyeva E.N., Denisova T.G. et al. Provision with vitamin D and correction of its deficit during pregnancy. Practical medicine. 2017; 5 (106): 18–21 (in Russ.)].
  27. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
  28. Tripkovic L., Lambert H., Hart K. et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012; 95 (6): 1357–64. DOI: 10.3945/ajcn.111.031070
  29. Binkley N., Gemar D., Engelke J. et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011; 96 (4): 981–8. DOI: 10.1210/jc.2010-0015
  30. Romagnoli E., Mascia M.L., Cipriani C. et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008; 93 (8): 3015–20. DOI: 10.1210/jc.2008-0350